Psychiatry and Neurology, Neurology · Stanford, CA
NPI
1952599839
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
300 Pasteur Dr
Stanford, CA, 94305
Phone (650) 723-4000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.3M
1,360 prescriptions
Company payments, 2025
$427
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug Diana Blum prescribed most often to Medicare patients was Rytary (Carbidopa/Levodopa), with 306 prescriptions and refills. In total Diana Blum wrote 1,360 Medicare prescriptions that cost $1.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Rytary Carbidopa/Levodopa | 306 | 532 | 34 | $268K |
| Neupro Rotigotine | 87 | 133 | 13 | $110K |
| Nourianz Istradefylline | 85 | 121 | 12 | $227K |
| Ongentys Opicapone | 70 | 92 | Under 11 | $60K |
| Rasagiline Mesylate Generic | 68 | 170 | 16 | $15K |
| Droxidopa Generic | 64 | 110 | 11 | $56K |
| Gabapentin Generic | 62 | 121 | 17 | $600 |
| Clonazepam Generic | 52 | 59 | Under 11 | $406 |
| Inbrija Levodopa | 38 | 38 | 15 | $145K |
| Donepezil Hcl Generic | 35 | 87 | Under 11 | $807 |
| Amantadine Amantadine Hcl | 32 | 66 | Under 11 | $2,135 |
| Mirtazapine Generic | 28 | 48 | Under 11 | $460 |
| Escitalopram Oxalate Generic | 28 | 40 | Under 11 | $484 |
| Memantine Hcl Generic | 27 | 66 | Under 11 | $1,724 |
| Sertraline Hcl Generic | 27 | 35 | Under 11 | $209 |
Brand drugs: 699 claims; generic drugs: 661 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diana Blum $427 ($427 in general payments such as food, travel and fees) from 3 companies. The largest payer was MDD US Operations, LLC with $264.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.